RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 39 filers reported holding RENEO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,743,031 | +16.0% | 886,075 | 0.0% | 2.78% | -2.4% |
| Q2 2023 | $5,812,652 | +9.7% | 886,075 | 0.0% | 2.85% | +11.6% |
| Q1 2023 | $5,298,729 | +156.7% | 886,075 | 0.0% | 2.55% | +87.1% |
| Q4 2022 | $2,064,555 | -30.4% | 886,075 | 0.0% | 1.36% | -30.8% |
| Q3 2022 | $2,968,000 | +26.4% | 886,075 | 0.0% | 1.97% | +17.7% |
| Q2 2022 | $2,348,000 | -9.9% | 886,075 | 0.0% | 1.68% | +19.1% |
| Q1 2022 | $2,605,000 | -65.6% | 886,075 | 0.0% | 1.41% | -47.4% |
| Q4 2021 | $7,576,000 | +14.8% | 886,075 | 0.0% | 2.67% | +103.1% |
| Q3 2021 | $6,601,000 | -20.2% | 886,075 | 0.0% | 1.32% | -0.6% |
| Q2 2021 | $8,267,000 | – | 886,075 | – | 1.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $7,083,000 | 7.27% |
| Abingworth LLP | 2,073,957 | $6,077,000 | 1.72% |
| Aisling Capital Management LP | 886,075 | $2,605,000 | 1.41% |
| Novo Holdings A/S | 3,430,377 | $10,085,000 | 0.53% |
| NEA Management Company, LLC | 4,786,921 | $14,073,000 | 0.41% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 700,000 | $2,058,000 | 0.12% |
| Rock Springs Capital Management LP | 1,143,185 | $3,361,000 | 0.08% |
| Ikarian Capital, LLC | 185,597 | $546,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $294,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 17,648 | $52,000 | 0.00% |